corporate_fare
Bonsai Biotherapeutics AB
- Address
- Arvid Wallgrens Backe 20, Goteborgs Annedal
Sponsor Overview
assignment
1
sponsored trial
science
4
molecules
location_city
5
research centres
public
3
countries
person_search
6
investigators
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of TOL2 Safety, Tolerability, and Immune Response in Generalized Myasthenia Gravis Patients: A Phase I/IIa Randomized, Double-Blind, Placebo-Controlled Trial |  Denmark Germany Sweden | Not Yet Recruiting |
Data & Insights
science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 4 total (0% not shared with other sponsors)
This sponsor works with 4 molecules, of which 0 are not being studied by other sponsors.
hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 5 sites collaborated multiple times
This sponsor has worked with 5 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases1 trial322 other sponsors
- 2.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
5 centreslocation_city
assignment590Karolinska University Hospital
- Address
- Eugeniavagen 3, 171 64 Solna
location_city
assignment407Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)
- Address
- Ismaninger Strasse 22, Au-Haidhausen, 81675 Munich
location_city
assignment719Rigshospitalet
- Address
- Blegdamsvej 9, 2100 Copenhagen
location_city
assignment533Universitaetsklinikum Muenster AöR
- Address
- Von-Esmarch-Strasse 58, Sentrup, 48149 Munster
location_city
assignment595University Medical Center Hamburg-Eppendorf
- Address
- Martinistrasse 52, Eppendorf, 20246 Hamburg
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Bonsai Biotherapeutics AB.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.